Filing Details

Accession Number:
0000899866-14-000204
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-18 17:33:55
Reporting Period:
2014-09-16
Filing Date:
2014-09-18
Accepted Time:
2014-09-18 17:33:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1231949 Leonard Bell C/O Alexion Pharmaceuticals Inc
352 Knotter Drive
Cheshire CT 06410
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2014-09-16 32,047 $17.65 1,053,321 No 4 M Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-09-16 12,878 $159.87 1,040,443 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-09-16 19,169 $160.53 1,021,274 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-09-18 12,388 $161.45 1,008,886 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2014-09-16 32,047 $0.00 32,047 $17.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-04-09 2018-01-09 No 4 M Direct
Footnotes
  1. This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
  2. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $159.15 - $160.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  3. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $160.15 - $161.50. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  4. The sale of common stock reported by this Form 4 consists of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $161.45 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.